Cargando…

Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis

Primary biliary cholangitis (PBC) is a common condition that usually shows a progressive course towards cirrhosis without adequate treatment. Growth differentiation factor 15 (GDF15) plays multiple roles in various pathological conditions. The overall role of circulating GDF15 in cirrhotic PBC requi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhanyi, Liu, Yu, Li, Xiangyong, Wu, Yuankai, Yang, Fangji, Mo, Qiwan, Chong, Yutian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644315/
https://www.ncbi.nlm.nih.gov/pubmed/33178828
http://dx.doi.org/10.1155/2020/5162541
_version_ 1783606428501540864
author Li, Zhanyi
Liu, Yu
Li, Xiangyong
Wu, Yuankai
Yang, Fangji
Mo, Qiwan
Chong, Yutian
author_facet Li, Zhanyi
Liu, Yu
Li, Xiangyong
Wu, Yuankai
Yang, Fangji
Mo, Qiwan
Chong, Yutian
author_sort Li, Zhanyi
collection PubMed
description Primary biliary cholangitis (PBC) is a common condition that usually shows a progressive course towards cirrhosis without adequate treatment. Growth differentiation factor 15 (GDF15) plays multiple roles in various pathological conditions. The overall role of circulating GDF15 in cirrhotic PBC requires further investigation. Twenty patients with cirrhotic PBC, 26 with non-cirrhotic PBC, and 10 healthy subjects were enrolled between 2014 and 2018, and the serum levels of GDF15 were measured via enzyme immunoassay. The correlations between serum GDF15, weight, biochemical parameters, and the prognosis were analysed. Serum levels of GDF15 were significantly higher in cirrhotic PBC patients than in non-cirrhotic PBC patients or healthy controls (p = 0.009 and p < 0.001, respectively). The circulating GDF15 levels strongly correlated with weight changes (r = −0.541, p = 0.0138), albumin (r = −0.775, p < 0.0001), direct bilirubin (r = −0.786, p < 0.0001), total bile acids (r = 0.585, p = 0.007), and C-reactive protein (r = 0.718, p = 0.0005). Moreover, circulating GDF15 levels strongly correlated with the Mayo risk score (r = 0.685, p = 0.0009) and Model for End-stage Liver Disease score (r = 0.687, p = 0.0008). Determined by the area under the receiver operating characteristic curves, the overall diagnostic accuracies of GDF15 were as follows: cirrhosis = 0.725 (>3646.55 pg/mL, sensitivity: 70.0%, specificity: 69.2%), decompensated cirrhosis = 0.956 (>4073.30 pg/mL, sensitivity: 84.62%, specificity: 100%), and cirrhotic biochemical non-responders = 0.835 (>3479.20 pg/mL, sensitivity: 71.43%, specificity: 92.31%). GDF15 may be a useful and integrated biochemical marker to evaluate not only the disease severity and prognosis but also the nutrition and response to treatment of cirrhotic PBC patients, and its overall performance is satisfactory. Therapy targeting GDF15 is likely to benefit cirrhotic PBC patients and is worth further research.
format Online
Article
Text
id pubmed-7644315
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-76443152020-11-10 Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis Li, Zhanyi Liu, Yu Li, Xiangyong Wu, Yuankai Yang, Fangji Mo, Qiwan Chong, Yutian Biomed Res Int Research Article Primary biliary cholangitis (PBC) is a common condition that usually shows a progressive course towards cirrhosis without adequate treatment. Growth differentiation factor 15 (GDF15) plays multiple roles in various pathological conditions. The overall role of circulating GDF15 in cirrhotic PBC requires further investigation. Twenty patients with cirrhotic PBC, 26 with non-cirrhotic PBC, and 10 healthy subjects were enrolled between 2014 and 2018, and the serum levels of GDF15 were measured via enzyme immunoassay. The correlations between serum GDF15, weight, biochemical parameters, and the prognosis were analysed. Serum levels of GDF15 were significantly higher in cirrhotic PBC patients than in non-cirrhotic PBC patients or healthy controls (p = 0.009 and p < 0.001, respectively). The circulating GDF15 levels strongly correlated with weight changes (r = −0.541, p = 0.0138), albumin (r = −0.775, p < 0.0001), direct bilirubin (r = −0.786, p < 0.0001), total bile acids (r = 0.585, p = 0.007), and C-reactive protein (r = 0.718, p = 0.0005). Moreover, circulating GDF15 levels strongly correlated with the Mayo risk score (r = 0.685, p = 0.0009) and Model for End-stage Liver Disease score (r = 0.687, p = 0.0008). Determined by the area under the receiver operating characteristic curves, the overall diagnostic accuracies of GDF15 were as follows: cirrhosis = 0.725 (>3646.55 pg/mL, sensitivity: 70.0%, specificity: 69.2%), decompensated cirrhosis = 0.956 (>4073.30 pg/mL, sensitivity: 84.62%, specificity: 100%), and cirrhotic biochemical non-responders = 0.835 (>3479.20 pg/mL, sensitivity: 71.43%, specificity: 92.31%). GDF15 may be a useful and integrated biochemical marker to evaluate not only the disease severity and prognosis but also the nutrition and response to treatment of cirrhotic PBC patients, and its overall performance is satisfactory. Therapy targeting GDF15 is likely to benefit cirrhotic PBC patients and is worth further research. Hindawi 2020-10-29 /pmc/articles/PMC7644315/ /pubmed/33178828 http://dx.doi.org/10.1155/2020/5162541 Text en Copyright © 2020 Zhanyi Li et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Zhanyi
Liu, Yu
Li, Xiangyong
Wu, Yuankai
Yang, Fangji
Mo, Qiwan
Chong, Yutian
Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis
title Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis
title_full Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis
title_fullStr Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis
title_full_unstemmed Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis
title_short Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis
title_sort association between circulating growth differentiation factor 15 and cirrhotic primary biliary cholangitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644315/
https://www.ncbi.nlm.nih.gov/pubmed/33178828
http://dx.doi.org/10.1155/2020/5162541
work_keys_str_mv AT lizhanyi associationbetweencirculatinggrowthdifferentiationfactor15andcirrhoticprimarybiliarycholangitis
AT liuyu associationbetweencirculatinggrowthdifferentiationfactor15andcirrhoticprimarybiliarycholangitis
AT lixiangyong associationbetweencirculatinggrowthdifferentiationfactor15andcirrhoticprimarybiliarycholangitis
AT wuyuankai associationbetweencirculatinggrowthdifferentiationfactor15andcirrhoticprimarybiliarycholangitis
AT yangfangji associationbetweencirculatinggrowthdifferentiationfactor15andcirrhoticprimarybiliarycholangitis
AT moqiwan associationbetweencirculatinggrowthdifferentiationfactor15andcirrhoticprimarybiliarycholangitis
AT chongyutian associationbetweencirculatinggrowthdifferentiationfactor15andcirrhoticprimarybiliarycholangitis